The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk

Abstract

Background:

Pediatric acquired demyelinating syndromes (ADSs) are monophasic (mono-ADS) in 70% of cases and represent the first attack of multiple sclerosis (MS) in 30%. Secondhand tobacco smoke (SHS) exposure has been implicated as a risk factor for adult-onset MS. Little is known about whether SHS presents an additive risk beyond genetic factors and other environmental exposures associated with pediatric MS.

Methods:

This study examined SHS exposure in 216 children with mono-ADS and 81 children with MS. Interactions between SHS, HLA-DRB1*15 alleles, serum 25-hydroxyvitamin D concentrations, and serological evidence of remote Epstein–Barr virus (EBV) exposure were evaluated.

Results:

SHS exposure was more common in children with MS (37% exposed) compared to mono-ADS (29.5% exposed). Compared to mono-ADS, SHS exposure was not an independent risk factor for MS. When both SHS exposure and HLA-DRB1*15 were present, the odds for MS increased (odds ratio (OR) = 3.7; 95% confidence interval (CI): 1.17–11.9) compared to mono-ADS. Interactions between SHS and vitamin D or EBV did not associate with MS.

Conclusion:

Exposure to SHS is a risk factor for central nervous system (CNS) demyelination. Results suggest that SHS exposure and HLA-DRB1*15 interact to increase risk for MS in children diagnosed with mono-ADS.

Keywords

Multiple sclerosis epidemiology

Get full access to this article

View all access options for this article.

References

Thompson

Uitdehaag

Taylor

et al . Atlas of MS 2013. Multiple sclerosis international federation (MSIF), 2013, https://www.msif.org/about-us/who-we-are-and-what-we-do/advocacy/atlas/

Ascherio

Munger

Epidemiology of multiple sclerosis: From risk factors to prevention. Semin Neurol 2008; 28(1): 17–28.

Banwell

Bar-Or

Arnold

et al . Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol 2011; 10(5): 436–445.

Mikaeloff

Caridade

Tardieu

et al . Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007; 130: 2589–2595.

Manouchehrinia

Weston

Tench

et al . Tobacco smoking and excess mortality in multiple sclerosis: A cohort study. J Neurol Neurosurg Psychiatry 2014; 85: 1091–1095.

Jafari

Hoppenbrouwers

Hop

et al . Cigarette smoking and risk of MS in multiplex families. Mult Scler 2009; 15: 1363–1367.

CDC. Smoking & tobacco use: Data and statistics, 2014, http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm#toll

Hedstrom

Bomfim

Barcellos

et al . Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk. Int J Epidemiol 2014; 43(6): 1791–1798.

Polman

Reingold

Banwell

et al . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292–302.

10.

Benowitz

NL.

Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18(2): 188–204.

11.

Disanto

Magalhaes

Handel

et al . HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology 2011; 76: 781–786.

12.

Banwell

Krupp

Kennedy

et al . Clinical features and viral serologies in children with multiple sclerosis: A multinational observational study. Lancet Neurol 2007; 6(9): 773–781.

13.

Orton

S-M

Herrera

Yee

et al . Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5(11): 932–936.

14.

Dunn

Lee

Pavri

et al . Sex-based differences in multiple sclerosis (part I): Biology of disease incidence. Curr Top Behav Neurosci 2015; 26: 29–56.

15.

Andersson

Alfredsson

Källberg

et al . Calculating measures of biological interaction. Eur J Epidemiol 2005; 20(7): 575–579.

16.

Rothman

Greenland

Walker

AM.

Concepts of Interaction. Am J Epidemiol 1980; 112(4): 467–470.

17.

VanderWeele

TJ.

Reconsidering the denominator of the attributable proportion for interaction. Eur J Epidemiol 2013; 28(10): 779–784.

18.

Szklo

Nieto

Epidemiology: Beyond the basics. 2nd ed. Sudbury, MA: Jones & Bartlett Publishers, 2007.

19.

Johannsen

Susin

Gustafsson

Smoking and inflammation: Evidence for a synergistic role in chronic disease. Periodontol 2000; 64(155): 111–126.

20.

Arnson

Shoenfeld

Amital

Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34(3): J258–J265.

21.

Öckinger

Hagemann-Jensen

Kullberg

et al . T-cell activation and HLA-regulated response to smoking in the deep airways of patients with multiple sclerosis. Clin Immunol 2016; 169: 114–120.

22.

Mowry

Krupp

Milazzo

et al . Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67(5): 618–624.

23.

Hanwell

Banwell

Assessment of evidence for a protective role of vitamin D in multiple sclerosis. Biochim Biophys Acta 2011; 1812(2): 202–212.

24.

Van der Mei

Ponsonby

Dwyer

et al . Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study. BMJ 2003; 327: 316.

25.

Lee

Kim

K-N

Lim

Y-H

et al . Interaction of vitamin D and smoking on inflammatory markers in the urban elderly. J Prev Med Public Health 2015; 48(5): 249–256.

26.

Ren

Zhu

et al . The effect of cigarette smoking on vitamin D level and depression in male patients with acute ischemic stroke. Compr Psychiatry 2016; 65: 9–14.

27.

Ramagopalan

Valdar

Dyment

et al . Association of infectious mononucleosis with multiple sclerosis. Neuroepidemiology 2009; 32(4): 257–262.

28.

Bjørnevik

Riise

Bostrom

et al . Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study. Mult Scler J 2016; 23: 1018–1024.

29.

Simon

Van Der Mei

Munger

et al . Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 2010; 74(17): 1365–1371.

30.

Sundqvist

Sundström

Lindén

et al . Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology 2012; 79(13): 1363–1368.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB

0.15 MB